Previous 10 | Next 10 |
BASKING RIDGE, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today...
Senseonics Holdings (SENS) -16% after raising size of stock offering.Global Ship Lease (GSL) -14% after announcing public offering.Globalstar (GSAT) -13% after Morgan Stanley cuts to underweight on valuation.Broadwind (BWEN) -13% after guiding Q4 revenu...
Gainers: Vinco Ventures (BBIG) +312%.ADiTx Therapeutics (ADTX) +90%.Qutoutiao (QTT) +65%.Ideal Power (IPWR) +51%.BiondVax Pharmaceuticals (BVXV) +39%.Celsion (CLSN) +34%.Polar Power (POLA) +33%.Addex Therapeutics (ADXN) +28%.Pioneer Power Solutions (PPSI) +27%.Barnwell Industri...
Gainers: ADiTx Therapeutics (ADTX) +63%, Celsion (CLSN) +58%, Genetic Technologies (GENE) +39%, Addex Therapeutics (ADXN) +26%, ThermoGenesis Holdings (THMO) +19%.Losers: Obalon Therapeutics (OBLN) -25%, Cancer Genetics (CGIX) -24%, ...
Caladrius Biosciences (CLBS) drops 8% in premarket after announcing securities purchase agreements with certain investors to raise $25M via issuance of 12.5M shares and warrants to purchase up to an aggregate of 6.25M shares at $2/share. The 5 1/2-year warrants have an exercise pric...
BASKING RIDGE, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today...
Traders Are Flocking To Penny Stocks In Droves Penny stocks are shining bright right now. It doesn’t matter the day of the week or the stock price so long as it’s cheap. Every week we see these low-priced stocks dominating the top 10 most active list. On Tuesday, 7 out...
Gainers: Obalon Therapeutics (OBLN) +438%.Caladrius Biosciences (CLBS) +121%.Adamis Pharmaceuticals (ADMP) +72%.Steel Connect (STCN) +54%.Titan Medical (TMDI) +52%.Tiziana Life Sciences (TLSA) +50%.Iterum Therapeutics (ITRM) +40%.Dare Bioscience (DARE) +33%.17 Education & T...
Gainers: Obalon Therapeutics OBLN +181%, Caladrius Biosciences (CLBS) +137%, Titan Medical (TMDI) +36%, Tiziana Life Sciences (TLSA) +31%, Gritstone Oncology GRTS +12%.Losers: BioLineRx BLRX -24%, AcelRx Pharmaceuticals ACRX -17%,...
Caladrius Biosciences (CLBS) +120%.Aptorum Group (APM) +61% as Canada approves early-stage infection drug trial.Steel Connect (STCN) +54%.Dare Bioscience (DARE) +39%.ENDRA Life Sciences (NDRA) +36%.Lineage Cell Therapeutics (LCTX) +34%.Inuvo (INUV) +33%.eMagin Corporation (EMAN) +28...
News, Short Squeeze, Breakout and More Instantly...
Caladrius Biosciences Inc. Company Name:
CLBS Stock Symbol:
NASDAQ Market:
Caladrius Biosciences Inc. Website:
BASKING RIDGE, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), announced today that, based upon the final vote count certified by the independent inspector of elections for the annual meeting of ...
NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Virtual Investor Conference to be held on September 15 th . Individual investors, institutional ...
BASKING RIDGE, N.J., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company developing innovative therapies designed to treat or reverse disease, today announced tha...